Clinical supply fails when tools outpace the operating model. Clear workflows, governance, trusted records, and adoption strategies create scalable, reliable supply.
- R&D Capitalization Decisions That Drive Clinical Trial Supply
- The RTSM–EDC Integration Trap: Why Broken Workflows Still Undermine Trial Execution
- Building Win-Win Partnerships In Clinical Trial Supply
- The NDC-12 Ripple Effect: Why Clinical Trial Supply Chains Must Act Seven Years Early
- Bridging Preclinical Science And Trial Supply Success
- The New Reality Of Clinical Trial Logistics
- Drug Shortages In Clinical Trials: A Policy Blueprint
- Leading Clinical Trial Supply Teams: Insights And Best Practices
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Creating Accurate, Efficient, And Effective CDMO Project Proposals
To receive the most comprehensive project proposal possible, it is important to fill out any questionnaire as accurately and completely as possible.
-
Case Management Accelerates Shipment For SCN1A+ Dravet Syndrome Gene Therapy
Consider this streamlined, end-to-end solution that helped safeguard study timelines and ensured that patients with urgent medical needs could receive treatment without delay.
-
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers
Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
How Regional Logistics Strategy Supports Clinical Success In Europe
In an era where trial delays, customs bottlenecks, and fragmented regulations can derail even the most promising program, logistics has become a strategic asset.
-
Addressing Rare Disease Drug Product Manufacturing Challenges
Handling development and manufacturing challenges for orphan drugs requires experience, expertise and scalable technologies, along with a flexible and agile supply chain.
-
Clinical Supply Optimization: Process Improvement Accelerates Trials
A biopharmaceutical sponsor required the study start-up phase to be reduced to 91 days, involving comparator sourcing and blinding, kitting, packaging, labeling, and distribution to the sites.
-
Why RTSM Software Doesn't Belong Inside An All-In-One Suite
Don’t let administrative convenience compromise study integrity. Discover why purpose-built RTSM is essential for managing the technical complexities and specialized demands of modern trials.
-
Optimizing Clinical Trials In China With Strategic Solutions For Supply Chain
Plan proactively for clinical trials in China by aligning with National Medical Products Administration requirements and leveraging Free Trade Zones to streamline regulatory approvals and clinical supply importation.
-
Consolidating Clinical Supply Chain Operations With GxP Inventory
A Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.
-
Key Considerations For Emerging Companies When Selecting Packaging Components
Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.